The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Affiliation
Drug Commission of the German Medical Association
Country
Germany
Current Status, Position
Prof Dr med Wolf-Dieter Ludwig has been the Chairman of the Drug Commission of the German Medical Association and a Co-Editor of “DER ARZNEIMITTELBRIEF” (ISDB) since 2006. He also is a Member of the Management Board of the European Medicines Agency as representative of the European Doctor’s Association since 2013. From 2001 to August 2017, he was the Medical Director and Head of the Department for Haematology, Oncology, Tumour Immunology and Palliative Care at the HELIOS Clinic Berlin-Buch (formerly Charité).
Education
Prof Dr med Ludwig studied medicine at the universities of Louvain, Innsbruck and Berlin. He got his Master Degree and PhD from the Free University of Berlin, with Degrees for specialisation in internal medicine, transfusion medicine and haematology/oncology.
Research Area
Prof Dr med Ludwig’s research focuses on malignant hematologic disorders, precision medicine in oncology, regulatory science regarding approval of new drugs and postmarketing trials, independent drug information.
Conflict of interest: none